Drugs repurposing against SARS-CoV2 and the new variant B.1.1.7 (alpha strain) targeting the spike protein: molecular docking and simulation studies

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) is responsible for the global COVID-19 pandemic and millions of deaths worldwide. In December 2020, a new alpha strain of SARS-CoV2 was identified in the United Kingdom. It was referred to as VUI 202012/01 (Alpha strain modelled under inves...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Monu Pande, Debanjan Kundu, Ragini Srivastava
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2021-08-01
coleção:	Heliyon
Assuntos:	Molecular docking SARS-CoV2 spike protein Drug repurposing Alpha strain modelled Molecular dynamics and simulation COVID-19 pandemic
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S240584402101906X
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!